Navigation Links
Breakthrough Microarray-based Technology for the Study of Cancer

A new development in the analysis of cancer has been announced by Agilent Technologies. The company has reported an innovative method that enables the rapid advance of microarray-based comparative genomic studies in cancer. According to the report published in the December 24, 2004 issue of the Proceedings of the National Academy of Science (PNAS) in collaboration with the National Human Genome Research Institute, Agilent has developed a specialised microarray platform that uses total genomic DNA to overcome several scientific hurdles that previously impeded comparative genomic studies in cancer.

Chromosomal changes in cancer can be studied using Comparative genomic hybridization (CGH), which undergoes dramatic chromosomal changes, including loss, duplication and the translocation of DNA from one chromosome to another, as cancer develops. Understanding these changes is key to understanding cancer progression as well as developing possible therapies and prognostic and diagnostic tools. "Genomic alterations leading to changes in the number of gene copies present in cells are important events in the genesis and progression of cancer," said Michael Bittner of the Translational Genomics Research Institute. "Agilent has now taken array-CGH experiments into a new realm of resolution, sensitivity, and reproducibility that allows reliable detection of alterations at the scale of individual genes and even introns and exons. This advancement, along with the possibility it provides to correlate genomic copy alterations with mRNA abundance and protein abundance, is going to incite a huge body of experimentation and publication among the cancer research community." In the past, comparative genomic hybridization was performed through the optical imaging of whole chromosomes, a technique with limited sensitivity, resolution, quantification and throughput. Efforts in recent years to use microarrays to overcome these limitations have been hampered by inadequate sensitivity, sp
'"/>

Source:OBBeC


Page: 1 2

Related biology news :

1. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
2. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
3. Breakthrough isolating embryo-quality stem cells from blood
4. Breakthrough System for Understanding Ocean Plant Life Announced
5. Breakthrough: Scientists create worlds tiniest organic particles
6. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
7. Sciences Breakthrough of the Year: Watching evolution in action
8. Breakthrough for stem cell research
9. Breakthrough in understanding type-2 diabetes as key genes identified
10. Breakthrough vaccine to treat chemo-resistant ovarian cancer
11. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Breakthrough Microarray based Technology for the Study Cancer

(Date:12/11/2013)... means that there is an increasing yield gap between ... this issue, a team of scientists from the University ... understand the precise role soil structure plays in water ... and uptake of water by plants is essential both ... provides the means to maximise crop yield. The ...
(Date:12/11/2013)... incurable disorder that results from the death of certain neurons ... behavior and movements. , The neurodegenerative disease is caused by ... abnormal expansion in a part of DNA, called a CAG ... A healthy version of the Htt gene has between 20 ... lead to long repeats of the CAG triplet, resulting in ...
(Date:12/11/2013)... Researchers at the UNC School of Medicine and the ... of gene therapy led to a dramatic decline in ... a serious and costly bleeding condition that affects about ... around the world. , Before the gene treatment, the ... After receiving the novel gene therapy, though, they experienced ...
Breaking Biology News(10 mins):New study highlights key role soil structure plays in water uptake by crops 2Staying ahead of Huntington's disease 2New gene therapy proves promising as hemophilia treatment 2New gene therapy proves promising as hemophilia treatment 3
... Mice given a relatively new cancer drug can survive ... of smallpox virus, report scientists supported by the National ... the National Institutes of Health. The findings, say the ... useful in preventing adverse side effects of smallpox vaccine. ...
... scientists at the Salk Institute for Biological Studies report ... puzzles of developmental biology: the existence of a mechanism ... symmetrical while inner organs are arranged asymmetrically. , In ... biology, Juan-Carlos Belmonte and his Salk Institute colleagues found ...
... a common chemotherapy agent, researchers at UCLA's Jonsson Cancer ... found a way to move an important biomarker expressed ... in a cell ?where it could not be accessed ... The discovery, outlined in the cover article of May ...
Cached Biology News:Cancer drug slows poxvirus in mice 2Cancer drug slows poxvirus in mice 3Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 2Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 3UCLA cancer researchers shake loose hidden biomarker 2
(Date:12/11/2013)... 11, 2013 It is with deepest ... MD. Dr. Dulaney, one of the founding partners of ... changing people’s lives through advanced vision care . ... innovative technology solutions and the potential of individuals. While ... he retired from the practicing in 2006, many patients, ...
(Date:12/10/2013)... December 10, 2013 Tanja Dominko, ... at Worcester Polytechnic Institute (WPI), is the 2013 ... to one Slovenian native each year in recognition ... award also honors Dominko's international engagement in developing ... members with Slovenian colleagues to address important biomedical ...
(Date:12/10/2013)... 2013 According to ... Applications in Risk Assessment, Molecular Diagnostics, Disease ... Forensic Applications and Others) - Global Industry ... Size, Share, Opportunities and Forecast, 2013 - ... global biomarkers market for diagnostic applications such ...
(Date:12/10/2013)... FRANCISCO, Calif. , Dec. 10, 2013 /PRNewswire/ ... development of novel cancer therapeutics, today announced the ... therapeutic candidate, CB-839, at the 55 th ... is a potent, selective, orally available glutaminase inhibitor ... cell growth and survival.  "Glutaminase ...
Breaking Biology Technology:Barnet Dulaney Perkins Eye Center Regrets to Announce the Passing of David Dulaney, MD 2Worcester Polytechnic Institute’s Tanja Dominko Named Slovenian Ambassador of Science for 2013 2Worcester Polytechnic Institute’s Tanja Dominko Named Slovenian Ambassador of Science for 2013 3Worcester Polytechnic Institute’s Tanja Dominko Named Slovenian Ambassador of Science for 2013 4Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020 - Allied Market Research 2Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020 - Allied Market Research 3Calithera Biosciences Presents Preclinical Data for CB-839 at the 55th American Society of Hematology Annual Meeting 2
... West Michigan Science,& Technology Initiative and EDF Ventures ... medical device company, TransCorp, Inc. TransCorp is,temporarily located ... in,Grand Valley State University,s Cook-DeVos Center for Health ... novel surgical instruments,and implants. Other participants in the ...
... No Adverse Toxic Effects, ATLANTA, Nov. 10 ... medicines for the treatment of,age-related macular degeneration (AMD), ... Subspecialty Day at the American Academy of Ophthalmology,(AAO) ... from the ASaP (Assessment,of Safety of Intravitreal POT-4 ...
... Targets Governments, Hospitals and Public Health Care ... ... In an effort to help government,entities, hospitals and public health care ... aggressively,educating the industry about the proper storage and handling of vaccine,materials. ...
Cached Biology Technology:West Michigan's Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures 2Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial 2Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial 3Sentry Logistic Solutions Offers Outsourced Vaccine Storage & Distribution Service 2Sentry Logistic Solutions Offers Outsourced Vaccine Storage & Distribution Service 3
... includes 1. Scanning of gel(s) 2. ... tryptic in-gel digestion and peptide extraction ... 5. Acquisition of PMF (Peptide Mass ... TOF/TOF) 6. Acquisition of PFF (Peptide ...
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... This CLS number is a ... match Cornings product number. If showing ... the old Sigma-Aldrich number (R4276) or ... Material: cap polystyrene (expanded surface, easy ...
... neurons in vesicles called synaptosomes. ... bouton. Synaptosomes may be centrifuged ... cellular debris. Abnormalites in neurotransmitter release ... condtions. Conditions of release may ...
Biology Products: